8 completed, 2 terminated, 2 unknown, 1 recruiting. 13 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 8, Terminated 2, Unknown 2, Recruiting 1 |
| Phase 2 | 4 | Completed 2, Terminated 2 |
Follow Heart Failure, Diastolic: new trials by email Literature Review of Heart Failure, Diastolic trials Research Report on Heart Failure, Diastolic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selenium Intervention Registry Randomized Trial in Heart Failure Selenium Supplement, Placebo - Heart Failure, Heart Failure and Reduced Ejection Fraction | Phase 3 | Recruiting | Skane University Hospital | 4326 | 2026-04-01 | 2026-04-22 |
| A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction Low calorie meal replacement plan, Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy, Transthoracic echocardiography - Heart Failure With Preserved Ejection Fraction, Heart Failure, Diastolic | Phase 2 / Phase 3 | Completed | University of Leicester | 66 | 2023-12-05 | 2026-07-22 |
| Optimized Management of Comorbidity in Heart Failure With Preserved Ejection Fraction in the Elderly (>60 Years) Screening and treatment of comorbidities, Placebo Comparator - Heart Failure, Diastolic | Phase 3 | Unknown | Göteborg University | 410 | 2014-09-01 | 2018-09-07 |
| Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction LCZ696, Valsartan - Heart Failure With Preserved Ejection Fraction | Phase 3 | Completed | Novartis Pharmaceuticals | 4822 | 2014-07-18 | 2020-09-29 |
| Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer Eplerenone, Placebo - Breast Cancer | Phase 2 / Phase 3 | Terminated | University of British Columbia | 44 | 2014-05-01 | 2017-01-05 |
| A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF] Placebo, Udenafil (Zydena) - Diastolic Heart Failure | Phase 3 | Unknown | Seoul National University Hospital | 52 | 2012-10-01 | 2013-01-31 |
| Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction renal denervation - Diastolic Heart Failure, Hypertension | Phase 2 / Phase 3 | Terminated | UMC Utrecht | 60 | 2012-04-01 | 2021-05-03 |
| Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH Sildenafil, Placebo - Heart Failure, Diastolic, Pulmonary Hypertension | Phase 3 | Completed | University Medical Center Groningen | 52 | 2011-10-01 | 2016-03-21 |
| Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension bosentan, placebo - Heart Failure, Diastolic, Hypertension, Pulmonary | Phase 3 | Completed | University Teaching Hospital Hall in Tirol | 20 | 2009-01-01 | 2014-06-30 |
| Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study) Placebo, Sildenafil - Heart Failure | Phase 3 | Completed | Duke University | 216 | 2008-09-01 | 2014-07-23 |
| Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Spironolactone, Placebo - Cardiovascular Diseases, Heart Diseases | Phase 3 | Completed | Carelon Research | 3445 | 2006-08-01 | 2015-03-02 |
| Phosphodiesterase-5 (PDE5) Inhibition and Pulmonary Hypertension in Diastolic Heart Failure Sildenafil, Placebo - Pulmonary Hypertension, Diastolic Heart Failure | Phase 2 / Phase 3 | Completed | University of Milan | 44 | 2006-01-01 | 2012-06-15 |
| PIE II: Pharmacological Intervention in the Elderly II Spironolactone, Placebo - Diastolic Heart Failure, Heart Failure, Congestive | Phase 3 | Completed | Wake Forest University | 80 | 2005-04-01 | 2019-02-27 |
Heart Failure (5) · Hypertension, Pulmonary (3) · Breast Neoplasms (1) · Cardiovascular Diseases (1) · Diabetes Mellitus, Type 2 (1) · Heart Diseases (1) · Heart Failure, Systolic (1) · Hypertension (1) · Obesity (1)
Cardiovascular Diseases (12) · Heart Diseases (12) · Heart Failure (8) · Vascular Diseases (4) · Hypertension (3) · Lung Diseases (3) · Respiratory Tract Diseases (3) · Body Weight (1) · Breast Diseases (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Neoplasms (1) · Neoplasms by Site (1)
Sildenafil Citrate (3) · Spironolactone (2) · Bosentan (1) · Diagnostic Imaging (1) · Diet (1) · Echocardiography (1) · Electrocardiography (1) · Eplerenone (1) · Hematologic Tests (1) · Mass Screening (1) · Mineralocorticoid Receptor Antagonists (1) · Positron-Emission Tomography (1) · Sugars (1) · Valsartan (1) · Walk Test (1)
Carelon Research (1) · Duke University (1) · Göteborg University (1) · Novartis Pharmaceuticals (1) · Seoul National University Hospital (1) · Skane University Hospital (1) · UMC Utrecht (1) · University Medical Center Groningen (1) · University Teaching Hospital Hall in Tirol (1) · University of British Columbia (1) · University of Leicester (1) · University of Milan (1) · Wake Forest University (1)
Canada (4) · United States (4) · Netherlands (3) · Sweden (3) · Argentina (2) · Austria (2) · Brazil (2) · Norway (2) · Russia (2) · South Korea (2) · United Kingdom (2) · Australia (1) · Belgium (1) · Bulgaria (1) · China (1)
Dalane W. Kitzman, MD (1) · E S Hoendermis, MD PhD (1) · Eugene Braunwald, MD (1) · Gerry P McCann, MD (1) · Goo-Yeong Cho, MD, PhD (1) · Hyung-Kwan Kim, MD, PhD (1) · In-Chang Hwang, MD (1) · Kerry L. Lee, PhD (1) · Kyung-Hee Kim, MD (1) · Margot Davis, MD (1) · Michael X Fu, Professor (1) · Michiel Voskuil, MD, PhD (1) · Sean A Virani, MD, MSc, MPH (1) · Seung-Pyo Lee, MD (1)
PMID 35603667, PMID 36632831, PMID 37366061, PMID 42669134, PMID 19850207, PMID 21709061, PMID 22991405, PMID 23258572, PMID 23478662, PMID 23883653, PMID 24162898, PMID 24249049, PMID 24716680, PMID 24833648, PMID 25104521, PMID 25122186, PMID 25406305, PMID 25415957, PMID 25648577, PMID 25782985, PMID 26130119, PMID 26188003, PMID 26374849, PMID 26475142, PMID 26962133, PMID 27039126, PMID 27056882, PMID 27072860, PMID 27873388, PMID 28194841, PMID 28214792, PMID 28322009, PMID 28359411, PMID 28637881, PMID 28662936, PMID 29094152, PMID 29148144, PMID 29228101, PMID 29501806, PMID 29664406, PMID 29890892, PMID 29980595, PMID 30007557, PMID 30140899, PMID 30571191, PMID 30571192, PMID 30819379, PMID 30871349, PMID 31214914, PMID 31220936
R01AG018915 (1), U01HL084904 (1)